First Slide

Bioventure

Bioventure (BV) is a UAE-based biopharmaceutical company with a global network, focused on biotech and a wide range of pharmaceutical activities, delivering world-class solutions within the UAE and the Middle East.

Learn More

Third Slide

Alvotech and Bioventure
announce approval of AVT02

Alvotech (NASDAQ: ALVO) and Bioventure announced that the Egyptian Drug Authority (EDA) has approved the manufacturing and distribution of AVT02

Learn More

https://www.bioventure.ae/wp-content/uploads/2023/05/vision-copy.jpg

Crystal Clear

Strategic
Vision

To drive short, medium and long-term growth through.

https://www.bioventure.ae/wp-content/uploads/2023/05/portfolio-copy.jpg

Always Leading

Portfolio of Products

Including biosimilars, peptides, complex generics and innovations

https://www.bioventure.ae/wp-content/uploads/2023/03/expanding.jpg

Always Growing

Geographical Presence

In the Middle East and Africa, while expanding our operation globally

https://www.bioventure.ae/wp-content/uploads/2023/05/strategic-copy.jpg

Actively

Pursuing Partnerships

With pharmaceutical companies, specialists, and health tech companies

Bioventure Expands Distribution of

Biosimilars and Targeted Generic Pharmaceuticals Across Middle East and Africa

Bioventure is a company that specializes in biotech and generics commercialization, as well as tech transfer and in/out-licensing activities. Bioventure have signed an exclusive agreement for the distribution and commercialization of Alvotech’s biosimilar portfolio across the Middle East and Africa.

Moreover, Bioventure has exclusive partnership and distribution rights for the Adalvo targeted generic pharmaceuticals portfolio in the Middle East and North Africa region. The portfolio includes 30 generic pharmaceuticals focused on oncology, autoimmune and inflammation, and blood disease. Bioventure plans to expand its distribution of Adalvo pharmaceuticals continually.

Overall, Bioventure has established itself as a key player in the biotech and generics commercialization sector, with a particular focus on expanding distribution across the Middle East and Africa for both Alvotech’s biosimilar portfolio and Adalvo’s targeted generic pharmaceuticals portfolio.

Learn More

At Bioventure we are committed to making

Quality Healthcare Available to Everyone

Through our partnerships and distribution agreements, we strive to bring innovative and affordable healthcare solutions to patients across the Middle East and Africa, regardless of their location or financial resources.

Part of Global Healthcare Holding (GHH)

A leading invesment and business development group

Focused on health science in the UAE and beyond

Bioventure

Licensing & Investments

14May

Alliance Management

Frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking. Efficiently myocardinate market-driven innovation via open-source alignments. Dramatically engage high-payoff infomediaries rather than client-centric imperatives. Efficiently initiate world-class applications after client-centric infomediaries.

Licensing

14May

Investment

Progressively maintain extensive infomediaries via extensible niches. Dramatically disseminate standardized metrics after resource-leveling processes. Objectively pursue diverse catalysts for change for interoperable meta-services.

Investments

14May

Licensing

Committed to delivering high quality projects and innovate business solutions. Bring to the table win-win survival strategies to ensure proactive domination. Completely synergize resource taxing relationships via premier niche markets. Professionally cultivate one-to-one customer service with robust ideas.

Investments

14May

Portfolio

New normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution. Capitalise on low hanging fruit. Synergistically evolve 2.0 technologies rather than just in time initiatives. Quickly deploy strategic networks with compelling e-business. Credibly pontificate highly efficient manufactured products and enabled data.

Investments

Excellence is Our Specialty

Discover Bioventure

Product
Licensing

Product Registeration

Acquisition of Complements

Investments in Innovation

Investments in Life Science Businesses

We exist as a gateway for partnerships in accelerating

Significant Growth and Development in the Healthcare Industry

At Bioventure, we believe that partnerships are key to accelerating growth and development in the healthcare industry. We exist as a gateway for partnerships, bringing together leading biotech and pharmaceutical companies to create innovative solutions for patients in the Middle East and Africa. With our expertise in commercialization and distribution, we work closely with our partners to ensure that their products reach patients who need them the most.

Our commitment to partnerships extends beyond commercial interests. We believe that by collaborating with other companies and stakeholders in the healthcare industry, we can drive significant progress in research and development, improve patient outcomes, and contribute to the overall growth and development of the sector. By providing a platform for collaboration and innovation, we hope to create a brighter future for patients and healthcare providers in the Middle East and Africa, and beyond.

0123456789001234567890

Middle East Partners

0123456789001234567890

Africa Partners

012345678900123456789001234567890

Products

0123456789001234567890

Biosimilars

Bioventure Driving Growth and Innovation inPharma and Health Tech

Geographical Presence

Bioventure has geographical presense in the Middle East and Africa, while expanding our operations globaly.

Portfolio of Products

Bioventure has built a portfolio of products from different pharmaceutical domains including biosimilars, peptides, complex generics and innovations.

Bioventure is the leading regional entity with 13 biosimilars in it’s portfolio, and the leading local enitiy to handle biosimilar monoclonal antibodies in the UAE.

Strategic Vision

Bioventure has a clear strategic vision
to drive short, meduim and long-term growth through.

Pursuing Partnerships

Bioventure is actively pursuing partnerships with pharmaceutical companies, specialists, and innovative health tech companies looking for opportunities in the MEA region and beyond

Reach OutWorking Hours

Let’s get together and discuss how you can get a better health care. Just give us a call or a visit and we’ll make all of it happen.

Monday - Thursday8AM - 5PM

Friday8AM - 1:30PM

Saturday - SundayClosed

Visit us

Dubai Science Park (DSP)

HQ Complex, North Tower, Office 1008 & 1102, Dubai, United Arab Emirates

Call Us

+971 2 507 4445

Email Us

info@bioventure.ae

GlobalOne Healthcare Holding Companies

Bioventure is the investment arm of GlobalOne Healthcare Holding, a prominent investment and business development organization that operates within the healthcare industry in the UAE and internationally.

GlobalOne Healthcare is dedicated to providing comprehensive healthcare solutions that include fully integrated pharmaceuticals, manufacturing, distribution, health-tech, and hospital management. Their mission is to enhance patients’ quality of life by offering top-quality healthcare services and products.

As part of GlobalOne Healthcare, Bioventure is committed to investing in life science and biotech solutions to promote healthcare innovation and cater to the healthcare needs of patients in the Middle East and Africa.